No Relation Between Cognitive Impairment, Physical Disability and Serum Biomarkers in a Cohort of Progressive Multiple Sclerosis Patients
Despite significant efforts, there is still an existing need to identify diagnostic tools that would enable fast and reliable detection of the progressive stage of multiple sclerosis (MS) and help in monitoring the disease course and/or treatment effects. The aim of this prospective study in a group...
Saved in:
Main Authors: | Bartosz Gajewski, Iwona Karlińska, Małgorzata Domowicz, Igor Bednarski, Mariola Świderek-Matysiak, Mariusz Stasiołek |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/15/1/68 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biomarker combinations from different modalities predict early disability accumulation in multiple sclerosis
by: Vinzenz Fleischer, et al.
Published: (2025-01-01) -
Shared prognostic information in amyotrophic lateral sclerosis – systematic assessment of the patients’ perception of neurofilament light chain and the ALS functional rating scale
by: Lukas Maximilian Möhwald, et al.
Published: (2025-02-01) -
Prognostic Value of Cerebrospinal Fluid and Serum Neurofilament Light Chain in Amyotrophic Lateral Sclerosis: A Correlation Study
by: Siqi Dong, et al.
Published: (2025-01-01) -
Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale as a Novel Tool to Measure Disease Progression
by: Can Sun, et al.
Published: (2025-01-01) -
Serum neurofilament heavy chains as a biomarker of neuronal damage in multiple sclerosis relapse
by: P. Beliaziūnas, et al.
Published: (2021-03-01)